Shares of Transfer Technology International Corp. (OTC: TTIN) shares fell 5% to $0.01 this morning, pulling back from impressive gains yesterday on word that the company’s wholly owned subsidiary was approved as a vendor and sold its bed bug product to the country�s second largest drug store chain.
Subsidiary Organic Products International has been approved as a vendor and sold its Avenger Bed Bug Killer product to the second largest drug store chain in the U.S.
Commenting on the development, Bret Phillips, president of Phillips Sales and Marketing and a strategic marketing partner to Transfer Technology, said that the company has seen significant growth in new business for the sales of Avengers Bed Bug Killer in response to the bed bug crisis seen spreading across the country and North America.
Chris Trina, chairman and CEO of Transfer Technology International, said that Phillips has been working hard on getting vendor numbers from drug stores and online giants through his company PSM. Trina said that this could result into something quite large reasonably quickly for both the companies.
Transfer Technology shares have a 52-week range of $0.00-$0.07. In the last three trading sessions, the penny stock gained 250%. The stock is currently trading above its 50-day and below its 200-day moving average.
Transfer Technology is engaged in the acquisition, procurement and/or funding of research, intellectual property and technologies for commercial transfer to world-class business partners.
- Need fast service and cheap rates from a broker? Click here to see my favorite place to trade TTIN
- Want more? Check out the message board buzz for TTIN
- See which newsletters are recommending this stock pick
- Get breakingnews alerts on this stock:� http://thestockmarketwatch.com/
No comments:
Post a Comment